SCHEMBL6299912

SCHEMBL6299912

CC(C)(O)C1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22102118 1.00
SCHEMBL6299911 1.00
Hydrochloric Acid SCHEMBL29469830 0.97
SCHEMBL2644164 0.87
SCHEMBL1304445 0.87
SCHEMBL1266740 0.87
SCHEMBL20833338 0.85 KDM4E (0.40)
Hydrochloric Acid SCHEMBL15192972 0.85 KDM4E (0.48)
SCHEMBL16448784 0.85 KDM4E (0.40)
Hydrochloric Acid SCHEMBL1266559 0.85 KDM4E (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107641114-B Compound as isocitrate dehydrogenase inhibitor and application thereof 南京圣和药业股份有限公司 2022-07-01 CN disclosed
CN-109890806-B Compound as isocitrate dehydrogenase inhibitor and application thereof 南京圣和药业股份有限公司 2022-04-26 CN disclosed
EP-3489230-B1 CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF NANJING SANHOME PHARMACEUTICAL CO LTD (CN) 2021-12-08 EP disclosed
US-20210363152-A1 AMINOAZINE AMIDES HOFFMANN LA ROCHE (US) 2021-11-25 US disclosed
US-10961222-B2 Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2021-03-30 US disclosed
US-10961222-B2 Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2021-03-30 US disclosed
US-20190161473-A1 CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2019-05-30 US disclosed
US-20190161473-A1 CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2019-05-30 US disclosed
EP-3489230-A1 CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) 2019-05-29 EP disclosed
WO-2018014852-A1 CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF 南京圣和药业股份有限公司 2018-01-25 WO disclosed
US-8952185-B2 Production method of optically active dihydrobenzofuran derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-02-10 US disclosed
US-6930189-B2 Chiral ligand SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-08-16 US disclosed
US-6762306-B2 A N,O-BIS(DIPHENYLPHOSPHINO)-2-AZETIDINE DERIVATIVES, A TRANSITION METAL COMPLEX FOR USE AS HYDROGENATION CATALYSTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
US-20040110965-A1 Chiral ligand SUMITOMO CHEMICAL COMPANY, LIMITED 2004-06-10 US disclosed
US-20030191324-A1 Chiral ligand SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-09 US disclosed
EP-1241174-A1 Chiral ligands for asymmetric synthesis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-09-18 EP disclosed